DXCM Q3 2018 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$267M+44.5% YoY

Gross Profit

$169M63.2% margin

Operating Income

$14M5.2% margin

Net Income

$47M17.5% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+10.0%

Cash Flow

Operating Cash Flow

$57M

Free Cash Flow

$33M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$552M

Stockholders' Equity

$562M

Cash & Equivalents

$367M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$267M	$185M	+44.5%
Gross Profit	$169M	$127M	+32.8%
Operating Income	$14M	-$500,000	+2880.0%
Net Income	$47M	-$2M	+2430.0%

Geographic Segments

UNITED STATES

$202M76%

Non-US

$64M24%